These findings suggest that STX2, PDLIM7, LIMS2, KCNMB1, and IRAK3 may influence tumor progression and patient prognosis by modulating immunosuppressive infiltration and immune evasion within the tumor microenvironment. This evidence concerns the gene STX2 and neoplasm.